Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-9190 vs rocuronium for neuromuscular blockade maintenance during general anesthesia (Phase II, China)
CTR20260452Phase 2Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-9190, sponsored by Hengrui Therapeutics. Started Mar 2026; status: completed.
02
Drugs
HRS-9190
Beyond the preview
Go deeper on CTR20260452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260452.